ReviewThe FEBS journal2026
The emerging role of the Hippo signaling pathway in interorgan crosstalk.
Review in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Interorgan communication has emerged as a fundamental mechanism for maintaining systemic homeostasis, and its disruption contributes to the development of metabolic diseases, chronic inflammation, and cancer. The Hippo signaling pathway, traditionally known for controlling organ size, has recently been redefined as a context-dependent coordinator of systemic cues. By translating hormonal, metabolic, and microbial signals into coordinated cellular responses, Hippo signaling serves as a bidirectional communication hub that not only interprets systemic inputs but also generates "outputs" that connect multiple organ systems. In this review, we summarize how Hippo signaling integrates diverse stimuli within key interorgan axes (e.g., gut-liver, gut-pancreas, and adipose-peripheral organs), and how organ-specific Hippo activity, particularly in adipose tissue and skeletal muscle, generates systemic outputs influencing metabolism. This integration occurs through context-specific mechanisms, allowing Hippo signaling to adapt cellular programs to physiological or pathological conditions. Despite recent progress, the mechanisms by which Hippo signaling prioritizes and integrates multiple systemic inputs and transmits its effects across organs remain incompletely understood. Elucidating these processes will be crucial to establishing Hippo signaling as a unifying framework of interorgan communication and understanding its broader implications in systemic physiology and disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.